News
Eteplirsen Shows Efficacy for Duchenne Muscular Dystrophy
AVI BioPharma has reported positive Phase Ib/II study results of eteplirsen, an exon-skipping therapy for the treatment of Duchenne muscular dystrophy. The genetic muscle-wasting disease is caused by the absence of functional dystrophin, an essential muscle...
News
International Space Station Provides Pharmaceutical Insight
The International Space Station could be used to develop pharmaceutical products, including treatments for muscular dystrophy. The multilateral coordination board for International Space Station partner agencies has discussed the use of the facility as a...
News
Roche to Provide Early Infant Diagnosis HIV/AIDS Tests
Roche has received an exclusive contact from the National Health Laboratory Services in South Africa to provide support for the country's Early Infant Diagnosis programme, which aims to combat HIV/AIDS in children. Under the contact,...
News
GlaxoSmithKline Flu Jab Linked to Sleep Disorder
GlaxoSmithKline swine flu vaccine Pandemrix has been linked to narcolepsy in young people and should be used as a last line of protectionThe agency recommended that in persons under 20 years of age, Pandemrix may only be used if...
News
Europe Issues Warnings over Actos Cancer Risk
The European Medicine Agency has supported the continued use of Takeda's diabetes medication Actos, but has opted to increase warnings regarding bladder cancer risk. The move comes after both France and Germany suspended the use...
News
American Regent Recalls Batch of Calcium Gluconate Injections
American Regent has initiated a voluntary nationwide recall of a batch of calcium gluconate injections due to the presence of silicone particulates.The recall affects lot number 1,006 of calcium gluconate injection, USP, 10%, 100mL. American Regent...
News
Valeant to acquire Ortho Dermatologics
Valeant Pharmaceuticals International announced today that Valeant's subsidiaries, Valeant Pharmaceuticals North America LLC (VPNA) and Valeant International (Barbados) SRL (VIB), have signed an agreement to acquire the assets of the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.